Bizarre Patents
A small umbrella which may be removably attached to a beverage container in order to shade the beverage container from the direct rays of the sun.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7897612 | Substituted 1,8-naphthyridinecarboxamides for use as prolyl hydroxylase inhibitors The invention described herein relates to certain bicyclic heteroaromatic N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting ... | 03/01/2011 |
| 7893100 | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen... | 02/22/2011 |
| 7875643 | Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt thereof: wherein G is selected from a group consisting of: phenyl, pyridyl, benzothiaz... | 01/25/2011 |
| 7863299 | Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine D3 receptor modulators The present invention relates to novel compounds of formula (IC) or a salt thereof: wherein: p is an integer ranging from 0 to 4; R1 is independently selected from a group consisting of:... | 01/04/2011 |
| 7855298 | Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine Dreceptors The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt thereof: 1. wherein G is selected from a group consisting of: phenyl... | 12/21/2010 |
| 7838680 | Process for preparing heterocyclic derivatives The present invention relates to a novel process, useful for preparing key intermediates of formula (I) in the synthesis of various compounds, among them compounds which are potent and specific antagonists of D3 receptors, ... | 11/23/2010 |
| 7829594 | Calcilytic compounds Novel calcilytic compounds and methods of using them are provided. ... | 11/09/2010 |
| 7807698 | Azabicyclo[3.1.0]hexane derivatives as modulators of the dopamine D3 receptor The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt thereof: wherein G is selected from a group consisting of: phenyl, pyridyl, benzothiaz... | 10/05/2010 |
| 7803820 | 3-triazolylthiaalkyl-3-azabicyclo (3-1-O) hexanes and their use as dopamine D3 receptor ligands The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt thereof: wherein R1 is hydrogen or C1-4alkyl; R... | 09/28/2010 |
| 7799815 | Triazole derivatives as modulators of dopamine D3 receptors The present invention relates to novel compounds of formula (I) or a salt thereof: wherein: G is a 5- or 6-membered heteroaromatic group, or is a 9- or 10-membered bicyclic heteroaromatic ... | 09/21/2010 |
| 7790758 | Compounds which potentiate glutamate receptor and uses thereof in medicine This invention relates to potentiation of the glutamate receptor by novel compounds of formula (I): The invention also relates to the use of the derivatives in treating diseases and conditions mediated by potentiation of the ... | 09/07/2010 |
| 7776904 | Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine D3 receptors The present invention relates to novel compounds of formula (IA) or a salt thereof: wherein: A is attached to the phenyl group at the meta position or the para position relative to the cyclopropyl group, and is... | 08/17/2010 |
| 7759384 | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen... | 07/20/2010 |
| 7745642 | Glycine transport inhibitors The present invention relates to compounds of formula (I), or to salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The inv... | 06/29/2010 |
| 7745458 | Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine D3 receptors The present invention relates to novel compounds of formula (I) or a salt thereof: wherein: p is 0, 1, 2, 3, 4 or 5; R1 is independently selected from a group consisting of: halogen, hyd... | 06/29/2010 |
| 7741351 | Compounds which potentiate glutamate receptor and uses thereof in medicine This case discloses compounds of formula (I) wherein R1 is C1-6alkyl, haloC1-6alkyl, C2-6alkenyl, amino, monoC1-4alkylamino or diC1-4alkylamino; R2 and R3, which may be the same ... | 06/22/2010 |
| 7741020 | Methods for detecting Lp-PLA2 activity and inhibition of Lp-PLA2 activity This invention relates to methods for determining the activity of Lp-PLA2 in at least one sample from an animal. The invention also relates to methods for determining the inhibition of Lp-PLA2 activity in samples from animals that are administered an Lp-PLA2 inhibit... | 06/22/2010 |
| 7727988 | Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedione The present invention relates to novel compounds of formula (I)′ or a salt thereof: wherein G is selected from a group consisting of: phenyl, a 5- or 6-membered monocyclic heteroaryl gro... | 06/01/2010 |
| 7709497 | Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor The invention provides 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide, which is the compound of formula (I): or a salt thereof. ... | 05/04/2010 |
| 7705005 | Bicyclic heteroaromatic compounds The invention disclosed herein relates to compounds of formula (I) where the various groups are defined herein, and which are useful for treating inflammatory diseases such as atherosclerosis. ... | 04/27/2010 |
| 7691895 | Thrombopoietin activity modulating compounds and methods Disclosed herein are compounds of Formula (I), (II), and (III) pharmaceutical compositions comprising the same, methods of modulating the activity a thrombopoietin receptor using the same, methods of identifying compounds a... | 04/06/2010 |
| 7691893 | Chemical compounds The present invention relates to (1S,6R)-6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane, pharmaceutically acceptable salts, prodrugs or solvates thereof; processes for their preparation, intermediates used in these processes, pharmaceutical ... | 04/06/2010 |
| 7678801 | Compounds Novel substituted 2,4,8-trisubstituted 8H-pyrido[2,3-d]pyrimidin-7-one containing compounds and compositions, and their use use in therapy as CSBP/RK/p38 kinase inhibitors. ... | 03/16/2010 |
| 7674887 | Thrombopoietin mimetics Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comp... | 03/09/2010 |
| 7674792 | 5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one Invented is the compound (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6 -dichlorophenyl)amino]-1,3-thiazol-4(5H)-one, and/or pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are pharmaceutical compositions containing this compou... | 03/09/2010 |
| 7674789 | Compounds The present invention is directed to compounds of formula (I), (Ia),(Ic) and (Id), compositions, and uses thereof as an inhibitor of the p38 kinase, and wherein, inter alia R1 is C(Z)N(R10′ | 03/09/2010 |
| 7666857 | 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3′-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline An improved thrombopoietin mimetic, the choline salt of 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3′-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one. ... | 02/23/2010 |
| 7662804 | Thrombopoietin activity modulating compounds and methods Disclosed herein are novel diazenyl pyrazole compounds and related compounds. Also disclosed herein are methods of using these compounds for the treatment of diseases and conditions associated with modulating a thrombopoietin activity. ... | 02/16/2010 |
| 7652019 | 5,6-trimethylenepyrimidin-4-one compounds Pyrimidone compounds of formula (I): are inhibitors of the enzyme Lp-PLA2 and are of use in treating atherosclerosis. ... | 01/26/2010 |
| 7649010 | Carvedilol hydrobromide The present invention relates to a salt of carvedilol, corresponding compositions containing such a carvedilol salt or corresponding solvates thereof, and/or methods of using the aforementioned compound(s) in the treatment of certain disease states in mammals, in pa... | 01/19/2010 |
| 7648971 | Thrombopoietin mimetics Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comp... | 01/19/2010 |
| 7648720 | Dietary fiber delivery system A delivery system and method for delivering soluble dietary fibers in a chewable tablet form which is palatable and demonstrates a high degree of consumer acceptability. ... | 01/19/2010 |
| 7642276 | Fused heteroaryl derivatives for use as P38 kinase inhibitors Compounds of formula (I): wherein A is a 5-membered heteroaryl ring are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38, such as rheumat... | 01/05/2010 |
| 7642256 | Compounds which potentiate AMPA receptor and uses thereof in medicine Compounds of formula (I) and salts are provided: along with pharmaceutical compositions, uses in treating a disease or condition mediated by a reduction or imbalance in glutamate receptor function such as schizophrenia or c... | 01/05/2010 |
| 7638520 | Pyrimidine compounds Pyrimidone compounds of formula (I): are inhibitors of the enzyme Lp-PLA2 and are of use in treating atheroscelerosis. ... | 12/29/2009 |
| 7638081 | Injection molding process for the preparation of an oral delivery device for a pharmaceutically active agent An injection moulding process for the preparation of an oral delivery device comprising a core which contains a pharmaceutically active agent, having a coating with one or more openings leading to such a core. The invention also relates to devices produced by the pr... | 12/29/2009 |
| 7629462 | Tetrasubstituted pyrimidine compounds as chemical intermediates Novel substituted pyrimido[4,5-d]pyrimidin-2-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors. ... | 12/08/2009 |
| 7629350 | Compounds Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors. ... | 12/08/2009 |
| 7626055 | Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors Compounds of formula (I) or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors. ... | 12/01/2009 |
| 7626041 | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen... | 12/01/2009 |
